C000218213 Performance — JNL Moderate Allocation Fund, Class I
Data updated: 2026-08-26
C000218213 returned +4.41% year to date and +9.23% over one year to Jun 2026. Annualised returns are +9.60% over 3 years and +4.10% over 5 years. The fund trailed its US Multi-Cap Blend category average: $100 invested three years ago grew to $132, against $143 for the category, and to $109 over one year, against $116. Volatility over the past three years was 7.41% a year. In the 12 months to Jun 2026 the fund lost a net $248.5M, and assets reached $1.81B.
C000218213 Growth of $100
What $100 invested in JNL Moderate Allocation Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Multi-Cap Blend category average over the same months.
| Period | C000218213 | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $109 | $116 |
| 3 years (Jul 2023 – Jun 2026) | $132 | $143 |
| 5 years (Jul 2021 – Jun 2026) | $122 | $136 |
| Since data start (Apr 2020 – Jun 2026) | $163 | $190 |
C000218213 Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +4.41% |
| 1 year | +9.23% |
| 3 years (annualised) | +9.60% |
| 5 years (annualised) | +4.10% |
C000218213 Annual Returns
Calendar-year total returns of JNL Moderate Allocation Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +4.41% |
| 2025 | +11.07% |
| 2024 | +7.98% |
| 2023 | +12.28% |
| 2022 | −14.43% |
| 2021 | +7.75% |
| 2020 (Apr–Dec) | +25.97% |
C000218213 Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.5% | +1.6% | −4.2% | +3.7% | +1.6% | +0.3% | — | — | — | — | — | — |
| 2025 | +2.4% | +0.4% | −1.6% | +0.1% | +2.2% | +2.6% | +0.1% | +1.7% | +1.6% | +0.2% | +0.5% | +0.4% |
| 2024 | 0.0% | +1.5% | +1.8% | −2.8% | +2.4% | +0.9% | +2.1% | +1.8% | +1.4% | −1.6% | +2.8% | −2.4% |
| 2023 | +4.9% | −2.4% | +1.8% | +0.9% | −1.1% | +2.6% | +1.8% | −1.4% | −3.0% | −2.2% | +5.9% | +4.3% |
| 2022 | −3.4% | −1.9% | −0.5% | −5.1% | +0.1% | −5.0% | +4.5% | −2.5% | −6.2% | +2.2% | +4.8% | −1.8% |
| 2021 | −0.4% | +1.3% | +0.8% | +2.7% | +0.8% | +0.8% | +0.8% | +1.1% | −2.2% | +1.8% | −1.9% | +2.2% |
| 2020 | — | — | — | +6.0% | +3.4% | +2.0% | +3.1% | +2.1% | −1.2% | −0.5% | +6.2% | +2.5% |
C000218213 Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 7.41%
- 3-year Sharpe ratio: 0.69 (vs 4.5% risk-free rate)
- Best month: +5.91% (Nov 2023)
- Worst month: −4.18% (Mar 2026)
C000218213 Fund Flows
Monthly money in and out of JNL Moderate Allocation Fund, from SEC Form N-PORT.
- 12-month net flow: −$248.5M
- 12-month gross sales (incl. reinvestments): $143.6M
- Sales ÷ redemptions: 0.37×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $13.3M | $35.4M | −$22.0M |
| May 2026 | $9.4M | $31.3M | −$21.9M |
| Apr 2026 | $14.5M | $30.8M | −$16.3M |
| Mar 2026 | $10.2M | $32.0M | −$21.9M |
| Feb 2026 | $10.2M | $30.9M | −$20.7M |
| Jan 2026 | $12.2M | $28.3M | −$16.0M |
| Dec 2025 | $9.0M | $32.8M | −$23.8M |
| Nov 2025 | $14.6M | $33.8M | −$19.3M |
| Oct 2025 | $15.9M | $39.0M | −$23.2M |
| Sep 2025 | $10.4M | $32.1M | −$21.7M |
| Aug 2025 | $9.1M | $30.1M | −$21.0M |
| Jul 2025 | $14.9M | $35.6M | −$20.7M |
C000218213 Assets Under Management
Net assets of JNL Moderate Allocation Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $1.81B |
| 2026-03-31 | $1.78B |
| 2025-12-31 | $1.86B |
| 2025-09-30 | $1.90B |
| 2025-06-30 | $1.90B |
| 2025-03-31 | $1.87B |
| 2024-12-31 | $1.95B |
| 2024-09-30 | $2.06B |
| 2024-06-30 | $2.04B |
| 2024-03-31 | $2.10B |
| 2023-12-31 | $2.12B |
| 2023-09-30 | $2.04B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.